Aurora SpineASAPF 40 Days Payable is 83.91 as of Mar. 2026, which is 38% below its 10-year median of 135.78. GuruFocus rates ASAPF with a GF Score™ of 40/100 and a GF Value™ of $0.22 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Aurora Spine ranks better than 65.16% on this metric.
The historical rank and industry rank for Aurora Spine's Days Payable or its related term are showing as below:
ASAPF'
s Days Payable Range Over the Past 10 Years
Min: 100.35 Med: 135.78 Max: 259.75
Current: 100.35
During the past 13 years, Aurora Spine's highest Days Payable was 259.75. The lowest was 100.35. And the median was 135.78.
ASAPF's Days Payable is ranked better than 65.16% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs ASAPF: 100.35
Aurora Spine's Days Payable
declined
from Mar. 2025 (124.32) to Mar. 2026 (83.91).
It may suggest that Aurora Spineaccelerated paying its suppliers.
Aurora Spine Days Payable Related Terms
Aurora Spine Days Payable Historical Data
* Premium members only.
The historical data trend for Aurora Spine's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Aurora Spine's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurora Spine Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aurora Spine's Days Payable distribution charts can be found below:
* The bar in red indicates where Aurora Spine's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Aurora Spine's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aurora Spine (ASAPF) has a Days Payable of 83.91 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Aurora Spine and its competitors. This is 38% below median its historical median of 135.78. Over the past decade, Aurora Spine's Days Payable has ranged from 100.35 to 259.75. According to the industry distribution chart, Aurora Spine ranks #277 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 34.8%.
Is Aurora Spine's Days Payable too high?
Aurora Spine's current Days Payable of 83.91 is 38% below median its 10-year median of 135.78. Over the past 10 years, this metric has ranged from a low of 100.35 to a high of 259.75. The Medical Devices & Instruments industry median Days Payable is 67.87. Aurora Spine's value of 83.91 is 23.6% above this industry median. Based on the distribution chart, Aurora Spine ranks #277 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Aurora Spine has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Spine's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aurora Spine ranks #277 out of 795 companies for Days Payable. This puts Aurora Spine in the upper half of its industry. The industry median Days Payable is 67.87. Aurora Spine's value of 83.91 is 23.6% above this benchmark. Historically, Aurora Spine's own Days Payable has ranged from 100.35 to 259.75 over the past decade. While the company's 10-year median is 135.78 vs. the industry median of 67.87, Aurora Spine has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aurora Spine's current Days Payable of 83.91 is 23.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Aurora Spine and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aurora Spine's current Days Payable is 83.91, which is 38% below median its own 10-year median of 135.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Spine stock overvalued right now?
Based on GuruFocus' analysis, Aurora Spine (ASAPF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.22, compared to a current price of $0.16 — trading 29.5% below its estimated fair value. The current Days Payable is 83.91, which is 38% below median its 10-year median of 135.78 and 23.6% above the Medical Devices & Instruments industry median of 67.87. Aurora Spine's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Aurora Spine (ASAPF), the current Days Payable is 83.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aurora Spine (ASAPF) Overvalued in 2026?
Based on GuruFocus' analysis, Aurora Spine stock appears to be undervalued.
The current stock price of $0.16 is trading 29.5% below its estimated GF Value™ of $0.22.
GuruFocus considers Aurora Spine to be Possible Value Trap.
Key valuation signals for ASAPF:
Days Payable: 83.91 (38% below median its 10-year median of 135.78)
GF Value™: $0.22 vs. price of $0.16 (29.5% below fair value)
Industry Position: 23.6% above the Medical Devices & Instruments median (#277 of 795)
No single metric tells the full story. See the ASAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aurora Spine Corp is engaged in the development, manufacture, and sale of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.
40GF Score
Get the complete analysis for ASAPF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASAPF has been successfully added to your 
